Progesterone 200 mg Troche — Class II drug recall D-0811-2020
Terminated recall by MPRX, Inc. dba Medical Park Pharmacy, reported 2020-02-05, distributed in TX. Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
| Recall number | D-0811-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | MPRX, Inc. dba Medical Park Pharmacy, Dallas, TX, United States |
| Recall initiated | 2019-12-18 |
| Classified | 2020-01-29 |
| Reported by FDA | 2020-02-05 |
| Terminated | 2022-12-13 |
| Distributed | TX |
| Quantity | 1 bottles |
| Reason classes | labeling |
| Expiration dates | 2020-02-28 |
Product
Progesterone 200 mg Troche
Reason for recall
Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0811-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.